共 50 条
- [41] Sodium-glucose co-transporter-2 inhibitors in patients treated with immune checkpoint inhibitors Cardio-Oncology, 10
- [42] Effectiveness of sodium-glucose co-transporter-2 inhibitors on ischaemic heart disease DIABETES OBESITY & METABOLISM, 2020, 22 (07): : 1197 - 1206
- [44] Effect of sodium-glucose co-transporter-2 inhibitors on the levels of serum asprosin in patients with newly diagnosed type 2 diabetes mellitus DIABETOLOGY & METABOLIC SYNDROME, 2021, 13 (01):
- [45] Safety of Sodium-Glucose Co-Transporter 2 Inhibitors AMERICAN JOURNAL OF CARDIOLOGY, 2019, 124 : S45 - S52
- [46] Safety of Sodium-Glucose Co-Transporter 2 Inhibitors AMERICAN JOURNAL OF MEDICINE, 2019, 132 (10): : S49 - +
- [48] Effects of Sodium-Glucose Co-Transporter-2 Inhibitors on Markers of Vascular Damage JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (03):
- [49] Beyond the myocardium: Sodium-glucose co-transporter-2 inhibitors in heart failure DIABETES OBESITY & METABOLISM, 2021, 23 (05): : 1215 - 1218